CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Reconciliation of net income to cash provided by operating activities:
Net income	$ 42,076	$ 48,228
Add (deduct):
Depreciation and amortization	19,397	22,728
Provision for bad debt	697	1,189
Investment and other losses (gains) – net	1,436	(4,706)
Amortization of net premium on investments available-for-sale	5,114	5,396
Payments for title losses less than (in excess of) provisions	5,940	(5,026)
Adjustment for insurance recoveries of title losses	757	290
(Increase) decrease in receivables – net	(12,275)	4,966
Increase in other assets – net	(5,633)	(1,389)
Decrease in payables and accrued liabilities – net	(20,482)	(16,027)
Change in net deferred income taxes	8,749	3,159
Net income from equity investees	(1,813)	(1,933)
Dividends received from equity investees	2,053	1,912
Stock-based compensation expense	2,078	5,093
Other – net	(46)	106
Cash provided by operating activities	48,048	63,986
Investing activities:
Proceeds from investments available-for-sale sold	55,533	49,666
Proceeds from investments available-for-sale matured	33,867	25,562
Purchases of investments available-for-sale	(125,415)	(122,149)
Net purchases of short-term investments	(1,195)	(361)
Purchases of property and equipment, title plants and real estate – net	(12,411)	(13,615)
Cash paid for acquisition of businesses	(17,784)	(300)
Other – net	960	944
Cash used by investing activities	(66,445)	(60,253)
Financing activities:
Payments on notes payable	(18,848)	(30,210)
Proceeds from notes payable	48,043	51,956
Distributions to noncontrolling interests	(8,376)	(9,430)
Cash dividends paid	(21,100)	(20,800)
Cash paid on Class B Common Shares conversion	0	(12,000)
Payment of contingent consideration related to an acquisition	(1,298)	(2,002)
Purchase of remaining interest in consolidated subsidiary	(1,014)	(301)
Cash used by financing activities	(2,593)	(22,787)
Effects of changes in foreign currency exchange rates	3,964	1,775
Decrease in cash and cash equivalents	(17,026)	(17,279)
Cash and cash equivalents at beginning of period	185,772	179,067
Cash and cash equivalents at end of period	$ 168,746	$ 161,788